tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ARCT is currently covered by 9 analysts with an average price target of $23.67. This is a potential upside of $19.82 (60.58%) from yesterday's end of day stock price of $14.74.
Arcturus Therapeutics Holdings's activity chart (see below) currently has 115 price targets and 115 ratings on display. The stock rating distribution of ARCT is 60% BUY and 40% HOLD.
Analysts average stock forecasts to be materialized ratio is 46.63% with an average time for these price targets to be met of 204.94 days.
Highest price target for ARCT is $68, Lowest price target is $8, average price target is $23.67.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 18-Mar-2026. First documented stock forecast 18-Feb-2016.
Currently out of the existing stock ratings of ARCT, 9 are a BUY (60%), 6 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 18-Mar-2026
$22
$6.18 (39.06%)
$23
5 months 23 days ago
(18-Mar-2026)
6/7 (85.71%)
$15.45 (235.88%)
99
Buy Since 07-Feb-2020
$21
$5.18 (32.74%)
6 months 5 days ago
(05-Mar-2026)
1/7 (14.29%)
$13.75 (189.66%)
75
Buy Since 04-Mar-2020
$25
$9.18 (58.03%)
6 months 6 days ago
(04-Mar-2026)
5/14 (35.71%)
$17.42 (229.82%)
71
Hold Since 13-Nov-2025
$8
$-7.82 (-49.43%)
$7
6 months 6 days ago
(04-Mar-2026)
7/12 (58.33%)
$0.42 (5.54%)
142
Hold Since 12-Nov-2025
$9
$-6.82 (-43.11%)
9 months 29 days ago
(12-Nov-2025)
1/2 (50%)
$0.87 (10.70%)
175
What is ARCT (Arcturus Therapeutics Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on ARCT (Arcturus Therapeutics Holdings)?
Which analyst has the most public recommendations on ARCT (Arcturus Therapeutics Holdings)?
Which analyst is the currently most bullish on ARCT (Arcturus Therapeutics Holdings)?
Which analyst is the currently most reserved on ARCT (Arcturus Therapeutics Holdings)?
